149 related articles for article (PubMed ID: 33974555)
21. Activation of mTOR signaling pathway associated with adverse prognostic factors of epithelial ovarian cancer.
No JH; Jeon YT; Park IA; Kim YB; Kim JW; Park NH; Kang SB; Han JY; Lim JM; Song YS
Gynecol Oncol; 2011 Apr; 121(1):8-12. PubMed ID: 21276607
[TBL] [Abstract][Full Text] [Related]
22. Role of Somatostatin Signalling in Neuroendocrine Tumours.
Rogoza O; Megnis K; Kudrjavceva M; Gerina-Berzina A; Rovite V
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163374
[TBL] [Abstract][Full Text] [Related]
23. Somatostatin and dopamine receptor profile of gastroenteropancreatic neuroendocrine tumors: an immunohistochemical study.
Diakatou E; Kaltsas G; Tzivras M; Kanakis G; Papaliodi E; Kontogeorgos G
Endocr Pathol; 2011 Mar; 22(1):24-30. PubMed ID: 21287294
[TBL] [Abstract][Full Text] [Related]
24. PTEN promoter methylation and activation of the PI3K/Akt/mTOR pathway in pediatric gliomas and influence on clinical outcome.
Mueller S; Phillips J; Onar-Thomas A; Romero E; Zheng S; Wiencke JK; McBride SM; Cowdrey C; Prados MD; Weiss WA; Berger MS; Gupta N; Haas-Kogan DA
Neuro Oncol; 2012 Sep; 14(9):1146-52. PubMed ID: 22753230
[TBL] [Abstract][Full Text] [Related]
25. Expression of key mTOR pathway components in pancreatic ductal adenocarcinoma: A multicenter study for clinicopathologic and prognostic significance.
Zhou L; Yuan D; Zhang ZG; Liang ZY; Zhou WX; Yang JY; Jiang SH; Lu J; Zhang TP; You L; Guo JC; Zhao YP
Cancer Lett; 2017 Jun; 395():45-52. PubMed ID: 28279716
[TBL] [Abstract][Full Text] [Related]
26. Activation of Akt/mTOR pathway is associated with poor prognosis of nasopharyngeal carcinoma.
Wang W; Wen Q; Xu L; Xie G; Li J; Luo J; Chu S; Shi L; Huang D; Li J; Fan S
PLoS One; 2014; 9(8):e106098. PubMed ID: 25165983
[TBL] [Abstract][Full Text] [Related]
27. HSP90 expression and early recurrence in gastroenteropancreatic neuroendocrine tumors: Potential for a novel therapeutic target.
Gamboa AC; Ethun CG; Postlewait LM; Lopez-Aguiar AG; Zhelnin K; Krasinskas A; El-Rayes BF; Russell MC; Kooby DA; Staley CA; Cardona K; Maithel SK
Surg Oncol; 2020 Dec; 35():460-465. PubMed ID: 33080545
[TBL] [Abstract][Full Text] [Related]
28. CXCR4/CXCL12/CXCR7 axis is functional in neuroendocrine tumors and signals on mTOR.
Circelli L; Sciammarella C; Guadagno E; Tafuto S; del Basso de Caro M; Botti G; Pezzullo L; Aria M; Ramundo V; Tatangelo F; Losito NS; Ieranò C; D'Alterio C; Izzo F; Ciliberto G; Colao A; Faggiano A; Scala S
Oncotarget; 2016 Apr; 7(14):18865-75. PubMed ID: 26934559
[TBL] [Abstract][Full Text] [Related]
29. Expression of PTEN and mTOR in pancreatic neuroendocrine tumors.
Han X; Ji Y; Zhao J; Xu X; Lou W
Tumour Biol; 2013 Oct; 34(5):2871-9. PubMed ID: 23686804
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA-99b suppresses human cervical cancer cell activity by inhibiting the PI3K/AKT/mTOR signaling pathway.
Li YJ; Wang Y; Wang YY
J Cell Physiol; 2019 Jun; 234(6):9577-9591. PubMed ID: 30480801
[TBL] [Abstract][Full Text] [Related]
31. Immunohistochemical Analysis of mTOR Pathway-Related Proteins in Kaposiform Hemangioendothelioma.
Wang Z; Zheng C; Sun H; Yao W; Li K; Ma Y; Zheng S
Dermatology; 2020; 236(3):262-270. PubMed ID: 31896113
[TBL] [Abstract][Full Text] [Related]
32. Inverse expression of somatostatin and CXCR4 chemokine receptors in gastroenteropancreatic neuroendocrine neoplasms of different malignancy.
Kaemmerer D; Träger T; Hoffmeister M; Sipos B; Hommann M; Sänger J; Schulz S; Lupp A
Oncotarget; 2015 Sep; 6(29):27566-79. PubMed ID: 26259237
[TBL] [Abstract][Full Text] [Related]
33. Prognostic and predictive role of the PI3K-AKT-mTOR pathway in neuroendocrine neoplasms.
Gajate P; Alonso-Gordoa T; Martínez-Sáez O; Molina-Cerrillo J; Grande E
Clin Transl Oncol; 2018 May; 20(5):561-569. PubMed ID: 29124519
[TBL] [Abstract][Full Text] [Related]
34. miR-195 Regulates Proliferation and Apoptosis through Inhibiting the mTOR/p70s6k Signaling Pathway by Targeting HMGA2 in Esophageal Carcinoma Cells.
Li Y; Wu D; Wang P; Li X; Shi G
Dis Markers; 2017; 2017():8317913. PubMed ID: 28487599
[TBL] [Abstract][Full Text] [Related]
35. miRNA-99b-5p suppresses liver metastasis of colorectal cancer by down-regulating mTOR.
Li W; Chang J; Wang S; Liu X; Peng J; Huang D; Sun M; Chen Z; Zhang W; Guo W; Li J
Oncotarget; 2015 Sep; 6(27):24448-62. PubMed ID: 26259252
[TBL] [Abstract][Full Text] [Related]
36. [TP53BP2/ASPP2 inhibits autophagy of HepG2 cells by activating mTOR pathway in a p53-independent manner].
Xu P; Shi H; Jiao Y; Chen D; Shi H
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2019 Nov; 35(11):986-991. PubMed ID: 31878994
[TBL] [Abstract][Full Text] [Related]
37. Clinical and functional implication of the components of somatostatin system in gastroenteropancreatic neuroendocrine tumors.
Herrera-Martínez AD; Gahete MD; Pedraza-Arevalo S; Sánchez-Sánchez R; Ortega-Salas R; Serrano-Blanch R; Luque RM; Gálvez-Moreno MA; Castaño JP
Endocrine; 2018 Feb; 59(2):426-437. PubMed ID: 29196939
[TBL] [Abstract][Full Text] [Related]
38. Association Between Somatostatin Receptor Expression and Clinical Outcomes in Neuroendocrine Tumors.
Qian ZR; Li T; Ter-Minassian M; Yang J; Chan JA; Brais LK; Masugi Y; Thiaglingam A; Brooks N; Nishihara R; Bonnemarie M; Masuda A; Inamura K; Kim SA; Mima K; Sukawa Y; Dou R; Lin X; Christiani DC; Schmidlin F; Fuchs CS; Mahmood U; Ogino S; Kulke MH
Pancreas; 2016 Nov; 45(10):1386-1393. PubMed ID: 27622342
[TBL] [Abstract][Full Text] [Related]
39. Effects of bufalin on the mTOR/p70S6K pathway and apoptosis in esophageal squamous cell carcinoma in nude mice.
Liu Y; Wang X; Jia Y; Liu Y
Int J Mol Med; 2017 Aug; 40(2):357-366. PubMed ID: 28656204
[TBL] [Abstract][Full Text] [Related]
40. 4-Nonylphenol induces autophagy and attenuates mTOR-p70S6K/4EBP1 signaling by modulating AMPK activation in Sertoli cells.
Duan P; Hu C; Quan C; Yu T; Huang W; Chen W; Tang S; Shi Y; Martin FL; Yang K
Toxicol Lett; 2017 Feb; 267():21-31. PubMed ID: 28041982
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
